Nanobac Pharmaceuticals Incorporated Stock Today
| NNBP Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 55
|
Nanobac Pharmaceuticals is selling at 1.0E-4 as of the 30th of November 2024; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 1.0E-4. Nanobac Pharmaceuticals has over 55 % chance of experiencing financial distress in the next 2 years of operation and has generated negative returns for investors over the last 90 days. Equity ratings for Nanobac Pharmaceuticals Incorporated are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles . The company was founded in 1994 and is based in Tampa, Florida. Nanobac Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. More on Nanobac Pharmaceuticals Incorporated
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Nanobac Stock Highlights
| Chairman | John Stanton | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nanobac Pharmaceuticals Incorporated (NNBP) is traded on OTCCE Exchange in USA and employs 1 people. Nanobac Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 124.75 K. Nanobac Pharmaceuticals conducts business under Biotechnology sector and is part of Health Care industry.
Nanobac Pharmaceuticals Incorporated currently holds about 3.93 K in cash with (910.89 K) of positive cash flow from operations.
Check Nanobac Pharmaceuticals Probability Of Bankruptcy
Nanobac Stock Against Markets
Additional Tools for Nanobac Stock Analysis
When running Nanobac Pharmaceuticals' price analysis, check to measure Nanobac Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobac Pharmaceuticals is operating at the current time. Most of Nanobac Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Nanobac Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobac Pharmaceuticals' price. Additionally, you may evaluate how the addition of Nanobac Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.